NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/16/2023
Back to search
Official data from USPTO
MICROBIAL INSPIRED THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
MICROBIAL INSPIRED THERAPEUTICS
ST13
US500000088031390Class
1, 5, 42, 44
Filing
88031390
Registration
7055509
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
50
Latest update
07/08/2023
Trademark type
Word
Nice classes
1, 5, 42, 44
Filing date
07/10/2018
Registration date
05/16/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/16/2023
Last transaction
07/08/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
10/01/2022
First use in commerce
10/01/2022
Drawing code
4
Owner type
03
Owner location
WOBURN, MA
Examiner
DUONG,ANGELA GAW
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
AXIAL THERAPEUTICS, INC.
Axial Biotherapeutics, Inc.
Representatives
Ian W. Gillies KNOBBE, MARTENS, OLSON & BEAR, LLP
Technical classification
Nice Classes
Class 1Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical or biochemical productssmall moleculesprobiotic bacteriaprobiotic bacterial culturesand/or microbes for the treatment of gastrointestinal diseasesmicrobiome related conditionscentral nervous system diseases and disordersand/or any disease or disorder associated with leaky gut; microbeschemicals and/or biochemicals for use in the manufacture of pharmaceutical preparationsprobiotic supplementsand/or nutritional supplements; probiotic bacteriaprobiotic bacterial culturesand/or biochemicals for in vitro scientific or research use
Class 5
Pharmaceutical preparations and substances for the treatment of gastrointestinal diseasesmicrobiome related conditionscentral nervous system diseases and disordersand/or any disease or disorder associated with leaky gut
Class 42
Providing medical and scientific research information in the fields of pharmaceuticalsbiochemistrybiotechnologyclinical trials; drug discovery services; pharmaceutical research; research and development of new products; research in the fields of biochemistrybiotechnologyconducting clinical trials for others
Class 44
Providing medical information in the fields of pharmaceuticalsbiochemistrybiotechnologyclinical trials
Publications
History of USPTO decisions and trademark events.
50 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/16/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/11/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/10/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/23/2023
IUAF
USE AMENDMENT FILED
03/15/2023
EISU
TEAS STATEMENT OF USE RECEIVED
03/15/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/04/2022
EX5G
SOU EXTENSION 5 GRANTED
10/03/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
09/22/2022
EXT5
SOU EXTENSION 5 FILED
09/09/2022
EEXT
SOU TEAS EXTENSION RECEIVED
09/09/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/11/2022
EX4G
SOU EXTENSION 4 GRANTED
03/09/2022
EXT4
SOU EXTENSION 4 FILED
03/09/2022
EEXT
SOU TEAS EXTENSION RECEIVED
03/09/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/01/2021
EX3G
SOU EXTENSION 3 GRANTED
08/30/2021
EXT3
SOU EXTENSION 3 FILED
08/30/2021
EEXT
SOU TEAS EXTENSION RECEIVED
08/30/2021
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
03/24/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/10/2021
EX2G
SOU EXTENSION 2 GRANTED
02/08/2021
EXT2
SOU EXTENSION 2 FILED
02/08/2021
EEXT
SOU TEAS EXTENSION RECEIVED
02/08/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/18/2020
EX1G
SOU EXTENSION 1 GRANTED
09/16/2020
EXT1
SOU EXTENSION 1 FILED
09/16/2020
EEXT
SOU TEAS EXTENSION RECEIVED
09/16/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/17/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/21/2020
PUBO
PUBLISHED FOR OPPOSITION
01/21/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/01/2020
ALIE
ASSIGNED TO LIE
12/19/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/17/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/23/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/22/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/22/2019
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
05/29/2019
GPRA
PRIORITY ACTION E-MAILED
05/29/2019
CPRA
PRIORITY ACTION WRITTEN
05/29/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/30/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/29/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/29/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/30/2018
GNRT
NON-FINAL ACTION E-MAILED
10/30/2018
CNRT
NON-FINAL ACTION WRITTEN
10/30/2018
DOCK
ASSIGNED TO EXAMINER
10/29/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/14/2018
NWAP
NEW APPLICATION ENTERED
07/13/2018
Continuous trademark protection
Get notified about every new filing that threatens MICROBIAL INSPIRED THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.